Johns Hopkins HIV Guide
Delavirdine
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretroviral agents
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 4, 2016
Citation
Smith, Janessa, et al. "Delavirdine." Johns Hopkins HIV Guide, 2016. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545053/8.3/Delavirdine.
Smith J, Pham PA, Hsu AJ. Delavirdine. Johns Hopkins HIV Guide. 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545053/8.3/Delavirdine. Accessed June 3, 2023.
Smith, J., Pham, P. A., & Hsu, A. J. (2016). Delavirdine. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545053/8.3/Delavirdine
Smith J, Pham PA, Hsu AJ. Delavirdine [Internet]. In: Johns Hopkins HIV Guide. ; 2016. [cited 2023 June 03]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545053/8.3/Delavirdine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Delavirdine
ID - 545053
A1 - Smith,Janessa,Pharm.D. BCPS
AU - Pham,Paul,Pharm.D.
AU - Hsu,Alice,Pharm.D.
Y1 - 2016/10/04/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545053/8.3/Delavirdine
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
